Literature DB >> 468992

Relationship between alveolar PO2 and the rate of p-nitroanisole O-demethylation by the cytochrome P-450 pathway in isolated rabbit lungs.

A B Fisher, N Itakura, C Dodia, R G Thurman.   

Abstract

The relationship between alveolar PO2 and the rate of O-demethylation of p-nitroanisole, a model substrate for cytochrome P-450 -linked mixed-function oxidation, was evaluated in the isolated rabbit lung perfused with Krebs-Ringer bicarbonate buffer. The appearance of the product, p-nitrophenol, in the pulmonary perfusate was measured spectrophotometrically, The PO2 of the ventilating gas was varied with an accurate gas mixing pump and measured with an electrochemical O2 analyzer. In control lungs ventilated with 5% CO2 in air, the rate of p-nitrophenol production was approximately equal to 3.1 +/- 0.04 (mean +/- SE; n = 9) mumol/h per g dry wt. p-Nitrophenol production was unaltered when O2 in the ventilating gas was decreased to 1%, but it was depressed reversibly when alveolar O2 WAS 0.1% OR LESS AND WAS ABOLISHED DURING VENTILATION WITH 0.005% O2. The rate of the reaction was inhibited by 50% when alveolar PO2 was 0.3 mm Hg representing and intracellular [O2] OF approximately equal to muM. In the presence of metyrapone (0.1--1 mM), an inhibitor of cytochrome P-450-dependent reactions, p-nitrophenol production was 0.07--0.17 mumol/h per g dry wt. Ventilation of lungs with varying CO concentration in 20% O2 resulted in 50% inhibition of p-nitrophenol production when CO concentration was 10% (CO/O2 = 0.5). These results indicated that O-demethylation of p-nitroanisole by the lung is a cytochrome P-450-dependent reaction and that its rate is not affected until alveolar PO2 is less than 1 mm Hg.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468992      PMCID: PMC372180          DOI: 10.1172/JCI109522

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  Function of cytochrome P-450 of microsomes.

Authors:  T Omura; R Sato; D Y Cooper; O Rosenthal; R W Estabrook
Journal:  Fed Proc       Date:  1965 Sep-Oct

Review 2.  Pharmacokinetic function of the pulmonary circulation.

Authors:  Y S Bakhle; J R Vane
Journal:  Physiol Rev       Date:  1974-10       Impact factor: 37.312

3.  Energy utilization by the lung.

Authors:  A B Fisher; H Steinberg; D Bassett
Journal:  Am J Med       Date:  1974-09       Impact factor: 4.965

Review 4.  Cytochrome P-450 and its role in drug metabolism.

Authors:  J R Gillette; D C Davis; H A Sasame
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

5.  Metabolism of xenobiotics by the isolated perfused lung. Comparison with in vitro incubations.

Authors:  F C Law; T E Eling; J R Bend; J R Fouts
Journal:  Drug Metab Dispos       Date:  1974 Sep-Oct       Impact factor: 3.922

6.  Reductive drug metabolism in isolated perfused rat liver under restricted oxygen supply.

Authors:  R Jonen-Kern; H G Jonen; R R Schupp; K Minck; G F Kahl; K J Netter
Journal:  Xenobiotica       Date:  1978-05       Impact factor: 1.908

7.  Studies on lung tumours. III. Oxidative metabolism of dimethylnitrosamine by rodent and human lung tissue.

Authors:  L den Engelse; M Gebbink; P Emmelot
Journal:  Chem Biol Interact       Date:  1975-12       Impact factor: 5.192

8.  The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; C McGowan
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

9.  Binding of a metyrapone spin label to microsomal cytochrome P-450.

Authors:  H H Ruf; W Nastainczyk
Journal:  Eur J Biochem       Date:  1976-06-15

10.  Cytochrome P450-linked p-nitroanisole O-demethylation in the perfused lung.

Authors:  N Itakura; A B Fisher; R G Thurman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-08
View more
  1 in total

1.  Role of cytochrome P-450 in reperfusion injury of the rabbit lung.

Authors:  G K Bysani; T P Kennedy; N Ky; N V Rao; C A Blaze; J R Hoidal
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.